Morningstar1mon
2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)
Dec. 9, 2024 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced the poster presentation at the 2024 European Society For Medical Oncology (ESMO) Asia Congress to ...
Business Insider1mon
Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024
The ESMO IO poster is available on the Posters & Publications section of Immutep’s website. Immutep is a clinical-stage biotechnology company developing novel LAG-3 immunotherapy for cancer and ...